Phase I results for venetoclax plus high-dose cytarabine in children with relapsed/refractory AML June 18, 2019
Ribomic presents positive topline results from phase I/IIa SUSHI study of RBM-007 in wet AMD June 18, 2019
Regeneron Pharmaceuticals initiates phase II study of REGN-5069 in osteoarthritis of the knee June 18, 2019
Positive 6-month results from phase II open-label study of ATI-502 in androgenetic alopecia June 18, 2019
RSS